pan - KRAS药物研发
Search documents
加科思-B:Early pan-KRAS clinical data unveils potential first-in-class blockbuster-20260312
Zhao Yin Guo Ji· 2026-03-12 01:24
12 Mar 2026 CMB International Global Markets | Equity Research | Company Update Jacobio (1167 HK) Jacobio (1167 HK) - Early pan- Early blockbuster pan-KRAS clinical data unveils potential first-in-class blockbuster | Target Price | HK$10.34 | | --- | --- | | (Previous TP | HK$10.34) | | Up/Downside | 45.8% | | Current Price | HK$7.09 | China Healthcare Andy WANG (852) 3657 6288 andywang@cmbi.com.hk | Earnings Summary | | --- | | (YE 31 Dec) | FY24A | FY25A | FY26E | FY27E | FY28E | | --- | --- | --- | --- | ...